These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 9111201

  • 1. Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt mice.
    Beecham EJ, Owens JD, Shaughnessy JD, Huppi K, Bohr VA, Mushinski JF.
    Carcinogenesis; 1997 Apr; 18(4):687-94. PubMed ID: 9111201
    [Abstract] [Full Text] [Related]

  • 2. DNA repair defects associated with chromosomal translocation breaksite regions.
    Beecham EJ, Jones GM, Link C, Huppi K, Potter M, Mushinski JF, Bohr VA.
    Mol Cell Biol; 1994 Feb; 14(2):1204-12. PubMed ID: 8289801
    [Abstract] [Full Text] [Related]

  • 3. DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice.
    Beecham EJ, Mushinski JF, Shacter E, Potter M, Bohr VA.
    Mol Cell Biol; 1991 Jun; 11(6):3095-104. PubMed ID: 1710024
    [Abstract] [Full Text] [Related]

  • 4. Genomic instability in B-cells and diversity of recombinations that activate c-myc.
    Janz S, Jones GM, Müller JR, Potter M.
    Curr Top Microbiol Immunol; 1995 Jun; 194():373-80. PubMed ID: 7895512
    [Abstract] [Full Text] [Related]

  • 5. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M, Morrison S, Wiener F, Zhang XK, Miller FW.
    J Natl Cancer Inst; 1994 Jul 20; 86(14):1058-65. PubMed ID: 8021954
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.
    Mock BA, Krall MM, Dosik JK.
    Proc Natl Acad Sci U S A; 1993 Oct 15; 90(20):9499-503. PubMed ID: 8105477
    [Abstract] [Full Text] [Related]

  • 8. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR, Jones GM, Potter M, Janz S.
    Cancer Res; 1996 Jan 15; 56(2):419-23. PubMed ID: 8542601
    [Abstract] [Full Text] [Related]

  • 9. Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells.
    Müller JR, Potter M, Janz S.
    Proc Natl Acad Sci U S A; 1994 Dec 06; 91(25):12066-70. PubMed ID: 7991585
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility.
    Zhang S, Shi W, Ramsay ES, Bliskovsky V, Eiden AM, Connors D, Steinsaltz M, DuBois W, Mock BA.
    J Biol Chem; 2019 Nov 08; 294(45):16756-16764. PubMed ID: 31548308
    [Abstract] [Full Text] [Related]

  • 12. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH, Degrassi A.
    Cell Immunol; 1993 Jan 08; 146(1):157-70. PubMed ID: 8425224
    [Abstract] [Full Text] [Related]

  • 13. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
    Potter M, Wiener F.
    Carcinogenesis; 1992 Oct 08; 13(10):1681-97. PubMed ID: 1423827
    [Abstract] [Full Text] [Related]

  • 14. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S, Babonits M, Klein G.
    Genes Chromosomes Cancer; 1996 Nov 08; 17(3):179-84. PubMed ID: 8946197
    [Abstract] [Full Text] [Related]

  • 15. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
    Shaughnessy JD, Owens JD, Wiener F, Hilbert DM, Huppi K, Potter M, Mushinski JF.
    Oncogene; 1993 Nov 08; 8(11):3111-21. PubMed ID: 8414513
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4.
    Mock BA, Hartley J, Le Tissier P, Wax JS, Potter M.
    Blood; 1997 Nov 15; 90(10):4092-8. PubMed ID: 9354679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.